ROSA Total Knee Post Market Study EMEA

NACompletedINTERVENTIONAL
Enrollment

252

Participants

Timeline

Start Date

December 15, 2020

Primary Completion Date

August 22, 2025

Study Completion Date

August 22, 2025

Conditions
Knee PainChronic OsteoarthritisAvascular Necrosis of the Femoral CondyleModerate Varus, Valgus or Flexion DeformitiesRheumatoid Arthritis
Interventions
PROCEDURE

Device: Persona Total Knee

The choice of intervention is defined by surgeons standard use of device 'Persona' in their standard of care practice

PROCEDURE

Device: NexGen Total Knee

The choice of intervention is defined by surgeons standard use of device 'Nexgen' in their standard of care practice

PROCEDURE

Device: Vanguard Total Knee

The choice of intervention is defined by surgeons standard use of device 'Vanguard' in their standard of care practice

Trial Locations (6)

Unknown

Cliniques Universitaires Saint-Luc, Brussels

Herzogin Elisabeth Hospital, Braunschweig

Evangelisches Waldkrankenhaus Spandau, Spandau

The Research Fund of Hadassah Medical Organization, Jerusalem

San Giuseppe Hospital, Arezzo

Hôpitaux Universitaires de Genève, Geneva

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Zimmer Biomet

INDUSTRY

NCT04338893 - ROSA Total Knee Post Market Study EMEA | Biotech Hunter | Biotech Hunter